Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT05224297 (PEDRO) for Radiotherapy Side Effect, PROMs is recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One study matched filter criteria
Card View
Back to Search
Medical University of ViennaPatient Experience Data in Radiation Oncology (PEDRO) 6,000 Immunotherapy Real-World Evidence
Clinical Trial NCT05224297 (PEDRO) is an observational study for Radiotherapy Side Effect, PROMs that is recruiting. It started on 1 October 2020 with plans to enroll 6,000 participants. Led by Medical University of Vienna, it is expected to complete by 1 January 2025. The latest data from ClinicalTrials.gov was last updated on 22 November 2024.
Brief Summary
The project is part of the overarching goal of improving patient-centric radiation oncology. This pilot project aims to develop an instrument that can be used to collect clinically relevant patient-reported outcome data on adverse effects during and after RT. This real-world evidence (RWE) database will be the basis to monitor and evaluate future technological developments, combination treatments (e.g. radioimmunothe...Show More
Official Title
Patient Experience Data in Radiation Oncology
Conditions
Radiotherapy Side EffectPROMsOther Study IDs
- PEDRO
- 2184/2019
NCT ID Number
Start Date (Actual)
2020-10-01
Last Update Posted
2024-11-22
Completion Date (Estimated)
2025-01-01
Enrollment (Estimated)
6,000
Study Type
Observational
Status
Recruiting
Keywords
radiation oncology
patient reported outcome
patient reported outcome
Arms / Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
breast | external beam photon therapy Patients receive external beam photon therapy for different tumor locations (groups). |
thorax | external beam photon therapy Patients receive external beam photon therapy for different tumor locations (groups). |
skin | external beam photon therapy Patients receive external beam photon therapy for different tumor locations (groups). |
abdomen | external beam photon therapy Patients receive external beam photon therapy for different tumor locations (groups). |
skull | external beam photon therapy Patients receive external beam photon therapy for different tumor locations (groups). |
head and neck | external beam photon therapy Patients receive external beam photon therapy for different tumor locations (groups). |
pelvis male | external beam photon therapy Patients receive external beam photon therapy for different tumor locations (groups). |
pelvis female | external beam photon therapy Patients receive external beam photon therapy for different tumor locations (groups). |
extremities | external beam photon therapy Patients receive external beam photon therapy for different tumor locations (groups). |
Primary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
radiation-related side effects | during radiotherapy and after (up until 5 years) |
Participation Assistant
Eligibility Criteria
Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
- all patients receiving external beam radiotherapy
- unable to independently answer questionnaires on radiation-induced side effects
Medical University of Vienna216 active studies to exploreStudy Responsible Party
Gerd Heilemann, Principal Investigator, Principal Investigator, Medical University of Vienna
Study Central Contact
Contact: Gerd Heilemann, PhD, 004314040072710, [email protected]
1 Study Locations in 1 Countries
Vienna
Medical University of Vienna, Vienna, Vienna, 1090, Austria
Gerd Heilemann, PhD, Contact
Andreas Renner, PhD, Contact
Recruiting